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Abstract
Background: Exercise in humans augments the mobilization
of circulating hematopoietic progenitor cells (CD34q) from
the bone marrow. We investigated the effect of inflammation
on erythroid marrow activity by mobilization of erythroid
progenitor cells (EPs) along with soluble markers of
erythropoiesis.
Methods: Ten healthy athletes who participated in an ultra-
distance foot race participated in the study. Peripheral blood
mononuclear cells were isolated, before (phase I), at the end
(phase II), and at 48 h post-race (phase III). EPs were detect-
ed as burst colony forming units (BFU-e) and colonies were
scored at day 14. Markers of inflammation (C-reactive pro-
tein, serum amyloid-A, interleukin-6, ferritin and S100B)
and bone marrow activity (erythropoietin, soluble transferrin
receptor and lipocalin-2) were assessed.
Results: An approximately three-fold decrease in BFU-e
number was observed at phase II. sTfR concentrations were
also decreased at phase II and remained decreased at phase
III. However, EPO and lipocalin-2 concentrations reached a
maximum value at phase II, with a tendency to decrease at
phase III.
Conclusions: These findings indicate that exercise-induced
inflammation modulates bone marrow homeostasis leading
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to an increase in leukocyte turnover and a decrease in ery-
throid compartment. It appears that lipocalin-2 is the main
factor that regulates the production and mobilization of EPs.
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Introduction
A competitive marathon race is a very stressful event and a
unique model of exercise-induced acute inflammation (1–6).
Acute-phase inflammation is characterized by increased
blood flow, in association with the accumulation of fluid,
leukocytes and inflammatory mediators known as cytokines
and acute-phase proteins (7, 8). Several of these mediators,
generated locally and transported systemically during acute
inflammation, are critical in the release, trafficking, and
differentiation of bone marrow stem cells (9, 10).
Exercise in humans has been shown to augment the mobi-
lization of circulating hematopoietic progenitor cells (HPCs)
(CD34q) from the bone marrow (11–13). Since strenuous
exercise causes peripheral neutrophilia and mild leukocyto-
sis, exercise-induced changes in CD34q cell counts could
possibly reflect an increase in leukocyte turnover.
However, intense exercise leads to a significant decrease
in red blood cells (RBC). The reduction in RBCs is caused
by hemolysis due to mechanical trauma and oxidative injury
to the cells (14, 15). Whether changes in numbers of ery-
throid progenitor cells (EPs) induced by exercise are related
to the degree of mechanical hemolysis is unclear. There
might be other factors that also affect RBC levels, such as
lipocalin-2. Lipocalin-2, a secreted member of the lipocalin
protein family, has been shown to inhibit the production of
RBCs in mice in vitro and in vivo (16). In humans, lipocalin-
2 appears to suppress the proliferation of erythroid cells in
vitro (17).
Until now, the effect of exercise-induced inflammation on
erythroid cells has been examined in terms of hemolysis. In
this study, we investigated the effect of inflammation on ery-
throid marrow activity by means of production of EPs along
with soluble markers of erythropoiesis in ultra-marathon run-
ners. Running an ultra-marathon is an extremely strenuous
event that might lead to cerebral ischemia. In order to inves-
tigate this hypothesis, we also measured protein S100b, a
well-known biomarker of brain tissue injury (18).
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Materials and methods
Subjects
‘‘Spartathlon’’ is an ultra-distance foot race of continuous, moderate
intensity exercise over a distance of 246 km, during which runners
attempted to cover the distance from Athens to Sparta. Fifty-two
runners competing in the 2006 ‘‘Spartathlon’’ race were fully
informed of the purpose and procedures of the study, and written
informed consent was obtained from all. The study protocol was
approved by the Bioethics Committee of the Harokopio University,
Laboratory of Nutrition and Clinical Dietetics. All experimental pro-
cedures conformed to the National Health and Medical Research
Council guidelines for experimentation with human subjects. Ten
of 52 athletes participated in the study. The median age was
42.8"1.4 years (range 33–53 years) and participants finished the
race in -36 h (mean and median running times were 32 h 8 min
and 30 h 2 min, respectively; range 25 h 17 min–34 h 43 min). Ten
sedentary healthy men (age 42.2"10.4 years) were studied as con-
trols. All subjects were non-smokers, clinically healthy, and with no
history of recent infection or other disease. During the run, the
ambient daily temperatures were between 58C and 368C and the
mean daytime relative humidity was 60%–85%.
Blood collection
Blood samples were obtained from the subject’s antecubital vein
with the subject in a sitting position. Samples were collected prior
to the start of the race, immediately following the race and at the
recovery period, 48 h after the end of the race. The same preana-
lytical conditions were used for all blood collections and storage of
samples for the 3 time intervals examined. The subjects consumed
water, electrolytes and carbohydrates ad libitum before, during and
after running. Peripheral venous blood samples were drawn into
plastic syringes under sterile conditions and transferred immediately
to tubes containing the appropriate anti-coagulant (citrate, EDTA,
heparin). In each experimental condition, aliquots of plasma and
serum were collected and stored frozen at –808C until analysis.
Samples for determination of burst colony forming units (BFU-e)
were processed within 24 h of collection.
Hematology and blood chemistry
Hematologic parameters were measured using the Siemens-ADVIA
120 whole blood analyzer (Siemens Healthcare Diagnostics, Tar-
rytown, NY, USA).
Serum erythropoietin (EPO), soluble transferrin receptor (sTfR)
and ferritin were measured in duplicate using a two site chemilu-
minescence immunoassay (Nichols Institute Diagnostics, CA,
USA). Concentrations of serum amyloid-A (SAA) and serum C-
reactive protein (CRP) were measured using particle-enhanced
immunonephelometry with the Dade Behring BN ProSpec nephe-
lometer (Siemens Healthcare Diagnostics, Liederbach, Germany).
Serum lipocalin-2 levels were determined by a solid phase ELISA
technique (R&D Systems, Minneapolis, MN, USA).
Serum S100B protein was analyzed with the electrochemilumi-
nescence immunoassay (ECLIA) on the ROCHE ELECSYS 2010
immunoassay analyzer (Roche Diagnostics GmbH, Mannheim,
Germany).
Cell culture assay for circulating EP
Mononuclear cells from peripheral blood samples were separated
using Ficoll (ds1.077 g/mL, Histopaque, Sigma, Gaithersburg,
MD, USA) and light-density cells were suspended in RPMI medium
(GIBCO Laboratories, Grand Island, NY, USA). Mononuclear cells
were plated at a concentration of 1=105 cells/mL in 0.8% methyl-
cellulose in Isscove’s modified Dulbeco’s medium supplemented
with 30% fetal calf serum, 1% de-ionized bovine serum albumin,
10–4 M 2-a-mercaptoethanol (Terry Fox Laboratory, Vancouver,
Canada), 2 units/mL recombinant human rhu-EPO (Amgen, Thou-
sand Oaks, CA, USA) and 100 ng/mL recombinant human stem cell
factor (R&D Systems, Minneapolis, MN, USA). Cells were cultured
in a humidified incubator containing 5% CO2 at 378C. Colonies
were scored at day 14 using previously described criteria (19). Data
are expressed as the number of colonies per milliliter of blood. All
experiments were performed in duplicate. The total count of the
plates was performed in duplicate and the mean values were used
in data analysis.
Statistical analysis
Data are presented as mean"SE, and statistical significance was set
at p-0.05. Analysis of variance (ANOVA) repeated measures test
was used to analyze time-course changes. All the statistical proce-
dures were performed using the STAT-GRAPHICS PLUS version
5.1 for Windows program (StatPoint Technologies Inc., Warrenton,
VA, USA).
Results
Inflammation and bone marrow activity markers
Markers of inflammation and bone marrow activity exam-
ined before (phase I), at the end (phase II), and 48 h post-
race (phase III) are shown in Table 1. Biomarkers of
inflammation including interlenkin-6 (IL-6), CRP, SAA and
ferritin were markedly increased by more than 6000-, 100-,
150- and 3-fold, respectively, over baseline at the end of the
race. However, IL-6 concentrations returned to normal values
by 48 h post-race (phase III), while CRP, SAA and ferritin
remained increased.
Hemoglobin and sTfR concentrations decreased progres-
sively from 143.4"2.9 g/L and 20.9"1.5 nmol/L, respec-
tively, at phase I to 124.3"2.2 g/L and 17.0"1.1 nmol/L at
phase III. Erythropoietin and lipocalin-2 concentrations
reached a maximum value at phase II, with a tendency to
decrease by phase III. Serum ferritin concentrations
increased significantly by phase II and remained increased
at phase III.
For the same time period, S100b protein followed the
same pattern (phase I: 0.13"0.01 mg/L, phase II: 0.29"0.01
and phase III: 0.13"0.01 mg/L). A moderately strong pos-
itive correlation between EPO and S-100b protein was found
in phase II (rs0.521, p-0.03), while this correlation was
absent in the other two phases (p)0.40 and p)0.08,
respectively).
Effects of the prolonged brisk exercise on erythroid
progenitors
EP decreased in peripheral blood nearly 3-fold at phase II
from 480.0"86.0 BFUe/mL in phase I to 177.0"29.5
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Table 1 Serum biochemical parameters (mean"SE) measured in athletes that successfully completed the 2006 ‘‘Spartathlon’’ foot-race
(ANOVA repeated measures).
Phase I Phase II Phase III Difference
Hemoglobin, g/L 143.0"3.0 140.4"3.0 124.2"2.3 p-0.0001
White blood cells, =109 L 6.5"0.3 13.5"0.6 6.0"0.2 p-0.0001
Platelets, =109 L 276"13 272"17 230"11 p-0.05
Ferritin, mg/L 49.7"7.4 121.7"13.3 150.0"13.9 p-0.0001
EPO, IU/L 13.5"1.5 51.9"12.2 21.1"3.4 p-0.001
sTfR, nmol/L 20.9"1.5 20.1"1.4 17.1"1.0b p)0.09
S100B, mg/L 0.14"0.01 0.29"0.03 0.13"0.02 p-0.0001
IL-6, ng/La 0.8"0.1 8376.0"1819.8 0.7"0.1 p-0.00001
aFrom ref. (20). bSignificant lower than phase I (pair-observation t-test p-0.01).
Figure 1 Numbers of erythroid progenitor cells.
Numbers of erythroid progenitor cells are depicted as box-plots
before (phase I), at the end (phase II) of and 48 h after (phase III)
the end of the ‘‘Spartathlon’’ race (boxes represent the interquartile
range; lines inside boxes represent the median value; whiskers
represent 5th and 95th percentiles).
BFUe/mL, and increased at phase III to 693.0"113.0 BFUe/
mL (Figure 1).
Discussion
Running a marathon is a model for exercise-induced inflam-
mation (21, 22). We have previously reported that prolonged
strenuous exercise induces an increase in plasma IL-6, CRP,
and SAA, reaching concentrations seen in major trauma, sep-
tic shock, systemic inflammation, or near-death (5). Consis-
tent with our previous study, we found that SAA and CRP
were extremely elevated, up to 150- and 116-fold, respec-
tively, supporting the concept of increased inflammation
(20). The concentration of serum ferritin was increased sig-
nificantly immediately after the race and remained increased
48 h post-race due to the acute-phase response. In addition,
a dramatic increase in the inflammation-responsive cytokine
IL-6 was observed at the end of the race. IL-6 also modulates
hematopoietic cell growth and differentiation (23). In mara-
thon runners, large increases in reticulocytes and leukocytes
have been observed (2, 11, 12, 24). Therefore, release of IL-
6 might be linked to increased turnover of leukocytes and
reticulocytes. We cannot make the same hypothesis as far as
it concerns erythroid precursor mobilization, since the BFU-
e number declined, despite the increased concentrations of
IL-6 (rs–0.735, p-0.0001).
The same pattern was also observed between the BFU-e
number and lipocalin-2. During the recovery process, lipo-
calin-2 concentrations tend to decrease, whereas the number
of EPs increases (Figures 1 and 2), (rs–0.672, p-0.001).
According to our results, it seems that during the course of
acute inflammation induced by prolonged strenuous exercise,
lipocalin-2 acts to suppress the production of EPs from the
bone marrow.
A similar profile was observed for EPO. An increase in
serum EPO at the end of the race with a tendency to decrease
by 48 h post-race was observed. It appears that during acute
inflammation, erythroid progenitors fail to respond appro-
priately to EPO stimulation. This hypothesis is further
supported by studies in dialysis patients (25–27) where
maintaining a stable hemoglobin concentration with EPO
supplementation often shows increased requirements for
EPO during inflammation or surgery (25–27). It is thus pos-
sible that failure of the bone marrow to respond to increased
EPO leads to a further incremental response. This in turn
results in the concentrations observed in ultra-marathon run-
ners. In addition, the increasing concentrations of EPO may
reflect a feedback mechanism that helps maintain erythroid
marrow homeostasis. It is also possible that the increase in
EPO concentrations in phase II reflects its neuroprotective
properties (28), since a positive correlation was found
between EPO and S100B concentrations. We can speculate
that EPO is released in order to avoid a probable episode of
brain ischemia. Thus, EPO may have a dual role in cases of
acute inflammation.
sTfR, another marker of overall erythropoietic activity,
decreased progressively reaching a minimum by 48 h post-
race. sTfR concentrations are decreased in situations char-
acterized by diminished erythropoietic activity, and are
increased when erythropoiesis is stimulated by hemolysis or
ineffective erythropoiesis (29). Consistent with our results,
the decline in sTfR concentrations reflects the diminished
activity of the erythroid marrow. BFU-e numbers decreased
markedly by the end of the race, and returned to baseline by
48 h post-race. On the contrary, sTfR concentrations did not
return to baseline but decreased further 48 h post-race. TfRs
exist on colony-forming unit-erythroid rather than on burst-
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Figure 2 Plasma concentrations of lipocalin-2.
Plasma concentrations of lipocalin-2 are depicted as box-plots
before (phase I), at the end (phase II) of and 48 h after (phase III)
the end of the ‘‘Spartathlon’’ race (boxes represent the interquartile
range; lines inside boxes represent the median value; whiskers
represent 5th and 95th percentiles).
forming unit erythroid. Their numbers increase to about
300,000 on early normoblasts and up to 800,000 on inter-
mediate normoblasts, before declining to about 100,000 on
reticulocytes and none on mature red cells (30). Thus, the
lower sTfR concentrations observed 48 h post-race are a
result of the reduced number of BFU-e at the end of the race.
Unfortunately, we were not able to measure sTfR concentra-
tions at a later time post-race where normalization of sTfR
values would be expected.
To date, only a few studies are available in the literature
that describe the impact of supra-maximal exercise on eryth-
ropoietic marrow activity. Most of the studies have focused
on the impact of exercise on the concentration of circulating
CD34q cells. The results of these studies differ. In 2002,
Bonsignore and colleagues demonstrated that the amount of
CD34q cells is not affected by a half-marathon or marathon,
but decreased significantly the morning following the race
(11). In a second report, the same group analyzed the impact
of maximal intensity rowing on the concentration of progen-
itor cells in 20 young rowers (12). Using fluorescence acti-
vated cell sorting (FACS) analysis or a clonogenic assay, a
significant increase in CD34q cells and BFU-es was evident
at the end of the race when compared to baseline. In 2008,
Wardyn and colleagues investigated the effects of exercise
on circulating CD34q and side population (SP) cell numbers
using flow cytometry (13). The study demonstrated that cir-
culating SP cells increased in number with exercise. On the
contrary, the levels of circulating CD34q cells did not
change significantly. In another report in 2008, Adam and
colleagues observed down regulation in circulating CD34q
cells after a marathon race (31).
Differences between these studies may in part be
explained by the different intensity and duration of exercise.
Therefore, one might speculate that the increase in progenitor
cells may be a consequence of mobilization processes occur-
ring in the bone marrow after short supra-maximal exercise,
whereas a longer time period leads to a reduction in the
amount of cells due to inflammation. The hypothesis that
inflammation influences the amount of circulating cells is
further supported by the negative correlation between inflam-
matory markers and circulating progenitor cells (31). In addi-
tion, completing a marathon or an ultra-marathon, as in our
study, leads to a significant rise of inflammatory markers,
such as IL-6, ferritin, SAA and CRP.
It seems that exercise-induced inflammation modulates
bone marrow homeostasis leading to increased leukocyte
turnover and a decreased erythroid compartment. According
to our results, it appears that lipocalin-2 is a factor that
regulates the production and mobilization of erythroid
progenitors.
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26. Bárány P, Divino Filho JC, Bergström J. High C-reactive pro-
tein is a strong predictor of resistance to erythropoietin in
hemodialysis patients. Am J Kidney Dis 1997;29:565–8.
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